Skip to content

Legal status · United States

Is Icatibant legal in the United States?

Written by Reviewed Sep 2026

ApprovedHormoneStudies in people cited: 5

Direct answer

Yes. Icatibant is an approved medicine in the United States. Its legal category is "FDA-approved, prescription only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 5 completed human trials are cited on its profile.

People given it
306
Found nothing
2

Legal category

FDA-approved, prescription only

FIRAZYR, NDA 022150, approved 25 August 2011, listed Prescription on 11 September 2026, with 6 generic icatibant acetate injections also listed Prescription.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Icatibant in the United States at a glance

Legal categoryFDA-approved, prescription only
NoteFIRAZYR, NDA 022150, approved 25 August 2011, listed Prescription on 11 September 2026, with 6 generic icatibant acetate injections also listed Prescription.
FDA approval statusFDA approved 25 August 2011 (FIRAZYR, NDA 022150) for sudden attacks of hereditary angioedema in adults, an inherited condition that causes bouts of severe swelling. Given as a shot under the skin. Listed as Prescription when we checked the FDA drug database (Drugs@FDA) on 11 September 2026, along with 6 generic icatibant acetate products approved between 2019 and 2024. It treats an attack once it starts. It does not prevent attacks, and it is not approved for swelling caused by ACE inhibitors, a type of blood pressure drug.
Studies in people5 of 8 sources on the profile
ReviewedSep 2026

The legal category and note come from the Icatibant profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.

What this means

  • 01

    FDA has approved Icatibant for at least one use named on its label. So a proper pharmacy-grade product exists in the United States, and pharmacies hand it out on prescription.

  • 02

    Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.

  • 03

    Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.

What Icatibant is

Icatibant is a lab-made peptide that blocks bradykinin. It was approved in 2011 as a shot for sudden attacks of hereditary angioedema, an inherited swelling disorder. In one large final-stage study it worked much faster than tranexamic acid tablets. In the other, it did not clearly beat a dummy shot. For swelling caused by blood pressure pills, the larger study against a dummy shot found no benefit.

Icatibant is a lab-made peptide, 10 building blocks long. It uses unnatural building blocks so the body's enzymes cannot chew it up.

How it works: In people, icatibant blocks the bradykinin B2 receptor. In hereditary angioedema, people are short of a protein called C1 inhibitor.

Approval history: FDA approved 25 August 2011 (FIRAZYR, NDA 022150) for sudden attacks of hereditary angioedema in adults, an inherited condition that causes bouts of severe swelling. Given as a shot under the skin. Listed as Prescription when we checked the FDA drug database (Drugs@FDA) on 11 September 2026, along with 6 generic icatibant acetate products approved between 2019 and 2024. It treats an attack once it starts. It does not prevent attacks, and it is not approved for swelling caused by ACE inhibitors, a type of blood pressure drug.

How FDA treats this kind of product

Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.

The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for Icatibant on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check FDA directly

Icatibant in sport and the military

Whether Icatibant is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up Icatibant by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Icatibant in other countries

Frequently asked questions

Is Icatibant legal in the United States?

Yes. Icatibant is an approved medicine in the United States. Its legal category is "FDA-approved, prescription only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 5 completed human trials are cited on its profile. Note: FIRAZYR, NDA 022150, approved 25 August 2011, listed Prescription on 11 September 2026, with 6 generic icatibant acetate injections also listed Prescription.

Can I buy Icatibant in the United States?

Only with a prescription. In the United States, Icatibant has the legal category "FDA-approved, prescription only". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives. Note: FIRAZYR, NDA 022150, approved 25 August 2011, listed Prescription on 11 September 2026, with 6 generic icatibant acetate injections also listed Prescription.

Is Icatibant FDA approved?

Yes. FDA status: FDA approved 25 August 2011 (FIRAZYR, NDA 022150) for sudden attacks of hereditary angioedema in adults, an inherited condition that causes bouts of severe swelling. Given as a shot under the skin. Listed as Prescription when we checked the FDA drug database (Drugs@FDA) on 11 September 2026, along with 6 generic icatibant acetate products approved between 2019 and 2024. It treats an attack once it starts. It does not prevent attacks, and it is not approved for swelling caused by ACE inhibitors, a type of blood pressure drug.. Current US legal category: "FDA-approved, prescription only". On the evidence, 5 completed human trials are cited on its profile.

Related compounds in the United States

Full research profile

How Icatibant works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Icatibant profile

This page is general information about the legal status of Icatibant in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.